ngµç×ÓÓÎÏ·

03
Ê×Ò³ / ½Ìѧ¿ÆÑÐ / ÕýÎÄ

³ÂСÊæÍŶÓÌá³öÖ§³ÖXȾɫÌå²»Ãô¸Ð¼ÙÉèµÄÌØÊâÖ¤¾Ý

¸å¼þȪԴ£º£º£ºÖÐɽҽѧԺ ±à¼­£º£º£ºÌ¸Ï£¡£¡£¡¢ÎâÁ¢¼á ÉóºË£º£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ ½ø»¯ÒÅ´«Ñ§ÖеÄÒ»¸öÖøÃûÕùÒéÊÇ£¬ £¬£¬ÊÇ·ñÐèҪͨ¹ý¼ÁÁ¿Åâ³¥À´½â¾öXȾɫÌåºÍ³£È¾É«ÌåÖ®¼äµÄ»ùÒò¼ÁÁ¿£¨X:AA£©²»Æ½ºâÎÊÌâ ¡£¡£¡£¡£¡£ScRNA-seqÊý¾Ý¿ÉÒÔ´Óµ¥Ï¸°ûˮƽÉîÈëµØÏàʶÕâ¸öÎÊÌâ ¡£¡£¡£¡£¡£È»¶ø£¬ £¬£¬¾ÙÐÐÆÊÎö֮ǰ£¬ £¬£¬±ØÐè×ÐϸÆÀ¹ÀscRNA-seqµÄ¹ÌÓÐÌØÕ÷£¨ÀýÈçÏ£º±ÐԵȣ©ÊÇ·ñ»áʹ²¸È鶯ÎïµÄX:AA±í´ï±ÈÂʱ¬·¢Îó²î ¡£¡£¡£¡£¡£

¿ËÈÕ£¬ £¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ³ÂСÊæ½ÌÊÚÍŶÓÔÚMolecular Biology and EvolutionÔÚÏß½ÒÏþÌâΪ¡±Human single-cell RNA-sequencing data supports the hypothesis of X chromosome insensitivity but is ineffective in testing the dosage compensation model¡±µÄÑо¿ÂÛÎÄ£¬ £¬£¬¶ÔscRNA-seqµÄ¹ÌÓÐÌØÕ÷¾ÙÐÐÁËÖÜÈ«µÄÑо¿£¬ £¬£¬ÒÔÕ¹ÏÖÆäÄÜ·ñ׼ȷĥÁ·¼ÁÁ¿Å⳥ģ×Ó ¡£¡£¡£¡£¡£

Ñо¿Ö°Ô±Ê×ÏÈʹÓÃÄ£ÄâscRNA-seqºÍbulk RNA-seqÊý¾Ý¼¯ÆÀ¹ÀÁËÁ½ÖÖ³£¼ûµÄX:AA»ùÒòÑ¡ÔñÕ½ÂÔ£¬ £¬£¬¼´°´»ùÒò±í´ïˮƽ¹ýÂ˺Ͱ´»ùÒò±í´ï±ÈÀý¹ýÂË ¡£¡£¡£¡£¡£ËûÃÇ·¢Ã÷ÕâÁ½ÖÖÕ½ÂÔ¶¼»á±¬·¢Ç¿µ÷µÄX:AA±í´ï±ÈÂÊ£¬ £¬£¬´Ó¶øÈËΪµØÖ§³Ö¼ÁÁ¿Å⳥ģ×Ó ¡£¡£¡£¡£¡£

2A142FA73A7504BF7B5FCE9DAD5_2870F575_278FC

±ðµÄ£¬ £¬£¬Ö»¹Üƽ¾ù±í´ïˮƽ±£´æÎó²î£¬ £¬£¬µ«Ñо¿Ö°Ô±·¢Ã÷scRNA-seqÊý¾Ý¿ÉÓÃÓÚ¼ì²âСÖÁ10%µÄXȾɫÌåÓ볣ȾɫÌåµÄ±í´ïÔëÉùµÄ²î±ð£¬ £¬£¬´Ó¶øÄܹ»Ñо¿¶Ô»ùÒò¼ÁÁ¿×ª±äØÔ²»Ãô¸ÐµÄ»ùÒòÂþÑÜ ¡£¡£¡£¡£¡£¶ÔSmart-seq2Êý¾ÝµÄÆÊÎöÏÔʾ£¬ £¬£¬Ó볣ȾɫÌåÏà±È£¬ £¬£¬XȾɫÌåµÄ±í´ïÔëÉùÔöÌíÁË10-15%£¬ £¬£¬XȾɫÌåÉϼÁÁ¿Ãô¸Ð»ùÒòÏÔÖøïÔÌ­ ¡£¡£¡£¡£¡£

69EB18A97592D02EFFB51AD31F4_03919D50_16AE3

×ÜÌå¶øÑÔ£¬ £¬£¬ÕâЩЧ¹ûÇ¿µ÷ÁËÔÚÚ¹ÊÍscRNA-seqÊý¾ÝʱÐèÒªºÜÊÇÉóÉ÷£¬ £¬£¬ÌØÊâÊÇÔÚ½ÏÁ¿²î±ð»ùÒòµÄ±í´ïˮƽʱ£¬ £¬£¬²¢ÎªXȾɫÌå²»Ãô¸ÐµÄ¼ÙÉèÌṩÁËÌØÁíÍâÖ¤¾Ý ¡£¡£¡£¡£¡£

ngµç×ÓÓÎÏ·³ÂСÊæ½ÌÊÚÊǸÃÎÄÕµÄΨһͨѶ×÷Õߣ¬ £¬£¬ÍŶӳÉÔ±22¼¶²©Ê¿Ñо¿Éú³Â¼ÒèµÊǸÃÎÄÕµÄΨһµÚÒ»×÷Õß ¡£¡£¡£¡£¡£

Ô­ÎÄÁ´½Ó£º£º£ºhttps://doi.org/10.1093/molbev/msaf004

¡¾ÍøÕ¾µØͼ¡¿